Skip to main content
SpringerLink
Log in

Die Imatinib-Plasmaspiegel korrelieren mit dem klinischen Nutzen

  • Journal Club / Gastrointestinale Stromatumoren
  • Unresektable oder metastasierte Gastrointestinale Stromatumoren
  • Published:
Info Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Klinikum der Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Deutschland

    Daniel Stanze

Authors
  1. Daniel Stanze
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel Stanze.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stanze, D. Die Imatinib-Plasmaspiegel korrelieren mit dem klinischen Nutzen. Info Onkol. 12, 32–33 (2009). https://doi.org/10.1007/BF03362636

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03362636

Schlüsselwörter

Search

Navigation